Cargando…

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans

Objectives: Cryptococcus neoformans is an opportunistic fungus that causes fatal meningoencephalitis especially in AIDS patients. There is an increasing need for discovery of new anti-cryptococcal drugs due to emergence of resistance cases in recent years. In this study, we aim to elucidate the anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Movahed, Elaheh, Tan, Grace Min Yi, Munusamy, Komathy, Yeow, Tee Cian, Tay, Sun Tee, Wong, Won Fen, Looi, Chung Yeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800180/ https://www.ncbi.nlm.nih.gov/pubmed/27047474 http://dx.doi.org/10.3389/fmicb.2016.00360

Ejemplares similares

Genome-Wide Transcription Study of Cryptococcus neoformans H99 Clinical Strain versus Environmental Strains
por: Movahed, Elaheh, et al.
Publicado: (2015)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Lung–infiltrating T helper 17 cells as the major source of interleukin-17A production during pulmonary Cryptococcus neoformans infection
por: Movahed, Elaheh, et al.
Publicado: (2018)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019)

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans
por: Bhattacharya, Somanon, et al.
Publicado: (2021)

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans
por: Rizzo, Juliana, et al.
Publicado: (2023)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro
por: Peng, Congyue Annie, et al.
Publicado: (2018)

Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
por: Oliveira, Natalia Kronbauer, et al.
Publicado: (2022)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Colony and Single Cell Level Analysis of the Heterogeneous Response of Cryptococcus neoformans to Fluconazole
por: Altamirano, Sophie, et al.
Publicado: (2018)

Necrotizing fasciitis as the initial presentation of disseminated infection with fluconazole-resistant Cryptococcus neoformans
por: Richardson, Timothy E, et al.
Publicado: (2014)

Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans
por: Dbouk, Nadir Hani, et al.
Publicado: (2019)

Synergic effect of simvastatin in combination with amphotericin B against environmental strains of Cryptococcus neoformans from northeastern Brazil: a prospective experimental study
por: Silva, Tássio Henrique Sousa, et al.
Publicado: (2020)

Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans
por: Ngamskulrungroj, Popchai, et al.
Publicado: (2012)

Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans
por: Andriani, Gabriella Maria, et al.
Publicado: (2023)

Minocycline and Fluconazole Have a Synergistic Effect Against Cryptococcus neoformans Both in vitro and in vivo
por: Kong, Qinxiang, et al.
Publicado: (2020)

Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade
por: Naicker, Serisha D., et al.
Publicado: (2020)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
por: Melendres, Javier, et al.
Publicado: (2022)

De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans
por: Banerjee, Dithi, et al.
Publicado: (2016)

Identification and Functional Demonstration of miRNAs in the Fungus Cryptococcus neoformans
por: Jiang, Nan, et al.
Publicado: (2012)

Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A
por: Florio, Ada Rita, et al.
Publicado: (2011)

Fluconazole-Induced Ploidy Change in Cryptococcus neoformans Results from the Uncoupling of Cell Growth and Nuclear Division
por: Altamirano, Sophie, et al.
Publicado: (2017)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Deletion of Cryptococcus neoformans AIF Ortholog Promotes Chromosome Aneuploidy and Fluconazole-Resistance in a Metacaspase-Independent Manner
por: Semighini, Camile P., et al.
Publicado: (2011)

Prevalence of plasmid-bearing and plasmid-free Chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia
por: Yeow, Tee Cian, et al.
Publicado: (2016)

Erratum: prevalence of plasmid-bearing and plasmid-free chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia
por: Yeow, Tee Cian, et al.
Publicado: (2016)

Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice
por: Khan, Azmat Ali, et al.
Publicado: (2016)

Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Δ mutant
por: Panepinto, John C., et al.
Publicado: (2010)

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress
por: Chang, Yun C., et al.
Publicado: (2018)

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC(50)
por: Gerlach, Elliot S., et al.
Publicado: (2021)

Lack of Association between Fluconazole Susceptibility and ERG11 Nucleotide Polymorphisms in Cryptococcus neoformans Clinical Isolates from Uganda
por: Atim, Priscilla Belbir, et al.
Publicado: (2022)

P092 Otilonium bromide is a potent antifungal agent against fluconazole- and flucytosine-resistant Cryptococcus neoformans strains
por: Zhen, Cheng, et al.
Publicado: (2022)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_dvumihuj0fo27ehp449lre6h6b